BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5109411)

  • 1. Intrathecal chemotherapy in Burkitt's lymphoma.
    Ziegler JL; Bluming AZ
    Br Med J; 1971 Aug; 3(5773):508-12. PubMed ID: 5109411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Burkitt's lymphoma with cyclophosphamide.
    Ziegler JL; Morrow RH; Fass L; Kyalwazi SK; Carbone PP
    Bibl Haematol; 1970; (36):701-5. PubMed ID: 5538541
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective therapy for Burkitt's lymphoma: high-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapy.
    Ramirez I; Sullivan MP; Wang Y; Martin RG; Butler JJ
    Cancer Chemother Pharmacol; 1979; 3(2):103-9. PubMed ID: 583137
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous lumbar intrathecal catheter for the administration of chemotherapy.
    Tobias JD; Oakes L; Foreman NK; Mahmoud H
    Med Pediatr Oncol; 1991; 19(4):301-3. PubMed ID: 2056974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate therapy and intrathecal chemoprophylaxis.
    Sullivan MP; Ramirez I
    J Clin Oncol; 1985 May; 3(5):627-36. PubMed ID: 3839010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
    Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
    J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
    J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
    Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR
    Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
    Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
    Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Burkitt's lymphoma involving the central nervous system.
    Ziegler JL; Magrath IT; Bluming AZ
    Afr J Med Med Sci; 1976 Jun; 5(2):121-4. PubMed ID: 829717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
    Geissler RG; Bergmann L; Hacker H; Knupp B; Walker B; Hoelzer D
    Eur J Haematol; 1997 Apr; 58(4):286-8. PubMed ID: 9186541
    [No Abstract]   [Full Text] [Related]  

  • 13. Central nervous system involvement in Burkitt's lymphoma.
    Ziegler JL; Bluming AZ; Morrow RH; Fass L; Carbone PP
    Blood; 1970 Dec; 36(6):718-28. PubMed ID: 5536703
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-lasting remission of Burkitt's disease in African children. Apropos of 6 cases].
    Plo JK; Rain JD; Andoh J; Tea DN; Essoh NP
    Med Trop (Mars); 1986; 46(2):141-6. PubMed ID: 3724411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of a patient with seropositive human immunodeficiency virus with high risk Burkitt's leukemia.
    Greenberg AL; Droller DG
    Cancer; 1994 Aug; 74(4):1261-4. PubMed ID: 8055447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of treatment failure in Burkitt's lymphoma.
    Williams CK; Folami AO; Seriki O
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):741-6. PubMed ID: 6683647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system involvement in American Burkitt's lymphoma.
    Sariban E; Edwards B; Janus C; Magrath I
    J Clin Oncol; 1983 Nov; 1(11):677-81. PubMed ID: 6689423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmoparesis due to Burkitt's lymphoma following cardiac transplantation.
    Liu GT; Kay MD; Byrne GE; Glaser JS; Schatz N
    Neurology; 1993 Oct; 43(10):2147-9. PubMed ID: 8413988
    [No Abstract]   [Full Text] [Related]  

  • 19. Intensive chemotherapy in patients with generalized Burkitt's lymphoma.
    Ziegler JL; Bluming AZ; Magrath IT; Carbone PP
    Int J Cancer; 1972 Sep; 10(2):254-61. PubMed ID: 4574467
    [No Abstract]   [Full Text] [Related]  

  • 20. Liposomal cytarabine in cerebrospinal fluid.
    Boyd K; Jenner M; Treleaven J; Kenny J; Rhoades E
    Br J Haematol; 2009 Jun; 145(6):679. PubMed ID: 19076172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.